1786 — Scivision Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Scivision Biotech, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	696	674	804	871	1,054
Net Total Accounts Receivable
Net Total Receivables	78.9	91.5	96.2	174	244
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	925	881	1,004	1,166	1,427
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,246	1,184	1,135	1,176	1,228
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	2,262	2,098	2,160	2,354	2,670
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	426	128	145	337	175
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	812	587	534	457	689
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,450	1,511	1,627	1,897	1,980
Total Liabilities & Shareholders' Equity	2,262	2,098	2,160	2,354	2,670
Total Common Shares Outstanding